Walter & Keenan Financial Consulting Co. MI ADV held its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 4,136 shares of the pharmacy operator’s stock at the end of the second quarter. Walter & Keenan Financial Consulting Co. MI ADV’s holdings in Walgreens Boots Alliance were worth $324,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in WBA. Reilly Financial Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after purchasing an additional 100 shares in the last quarter. Webster Bank N. A. raised its stake in shares of Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after purchasing an additional 235 shares in the last quarter. Orrstown Financial Services Inc. raised its stake in shares of Walgreens Boots Alliance by 14.1% during the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock worth $135,000 after purchasing an additional 213 shares in the last quarter. MCF Advisors LLC raised its stake in shares of Walgreens Boots Alliance by 68.2% during the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock worth $160,000 after purchasing an additional 780 shares in the last quarter. Finally, Founders Capital Management bought a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $161,000. Institutional investors and hedge funds own 60.16% of the company’s stock.

A number of equities research analysts have recently issued reports on WBA shares. Needham & Company LLC set a $94.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Monday, July 17th. Credit Suisse Group AG reissued a “buy” rating and set a $97.00 target price on shares of Walgreens Boots Alliance in a report on Thursday, July 13th. Leerink Swann set a $86.00 target price on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Friday, July 7th. Guggenheim reissued a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Finally, UBS AG reissued a “buy” rating and set a $96.00 target price (down from $97.00) on shares of Walgreens Boots Alliance in a report on Wednesday, August 23rd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the company. The company has an average rating of “Buy” and an average target price of $91.94.

Shares of Walgreens Boots Alliance Inc (WBA) opened at 76.95 on Friday. The firm has a market capitalization of $82.34 billion, a price-to-earnings ratio of 19.43 and a beta of 1.25. The stock’s 50 day moving average price is $80.22 and its 200 day moving average price is $81.23. Walgreens Boots Alliance Inc has a 12-month low of $75.18 and a 12-month high of $89.69.

Walgreens Boots Alliance declared that its board has approved a stock buyback program on Thursday, June 29th that allows the company to buyback $5.00 billion in shares. This buyback authorization allows the pharmacy operator to purchase up to 5.9% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Stockholders of record on Friday, August 18th were given a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. This represents a $1.60 annualized dividend and a dividend yield of 2.08%. Walgreens Boots Alliance’s payout ratio is 40.30%.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the completion of the transaction, the director now directly owns 19,151 shares in the company, valued at $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 13.50% of the stock is currently owned by insiders.

COPYRIGHT VIOLATION WARNING: This report was first reported by Watch List News and is owned by of Watch List News. If you are viewing this report on another domain, it was copied illegally and reposted in violation of United States & international trademark and copyright laws. The legal version of this report can be accessed at https://www.watchlistnews.com/walgreens-boots-alliance-inc-wba-holdings-maintained-by-walter-keenan-financial-consulting-co-mi-adv/1611627.html.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.